Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer

Background: [(177)Lu]Lu-PSMA-617 radioligand therapy (PSMA-RLT) could affect kidney and salivary gland functions in metastatic castration-resistant prostate cancer (mCRPC) patients. Methods: We retrospectively analyzed clinical, renal, and salivary scintigraphy data and salivary [(68)Ga]Ga-PSMA-11 l...

Descripción completa

Detalles Bibliográficos
Autores principales: Wollenweber, Tim, Zisser, Lucia, Kretschmer-Chott, Elisabeth, Weber, Michael, Grubmüller, Bernhard, Kramer, Gero, Shariat, Shahrokh F., Mitterhauser, Markus, Schmitl, Stefan, Vraka, Chrysoula, Haug, Alexander R., Hacker, Marcus, Hartenbach, Markus, Rasul, Sazan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482282/
https://www.ncbi.nlm.nih.gov/pubmed/34590608
http://dx.doi.org/10.3390/curroncol28050315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482282/
https://www.ncbi.nlm.nih.gov/pubmed/34590608
http://dx.doi.org/10.3390/curroncol28050315

Ejemplares similares